FDA Approves First ProAir HFA Generic

March 4, 2020

FDA Approves First ProAir HFA Generic

The U.S. FDA has announced its approval of the first generic of ProAir HFA (albuterol sulfate), one of the most commonly used metered-dose rescue inhalers. Generating similar generic copies of complex drugs on the market will help get these life-saving drugs into patients’ hands at lower costs. With all of the cost pressures affecting patients and the industry today, Yourway is enthusiastic about any measures that reduce healthcare costs.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Schedule a Meeting

GCSG 2026 European Knowledge Forum

October 14-15, 2026
Rome, Italy

Schedule a Meeting

Media

Articles

Your Clinical Trial Has 99 Problems. Logistics Shouldn’t Be One.

Open chat

Hello! How can I help you?